
Syndax Pharmaceuticals, Inc.
USD18.34
-0.05 (-0.27%)
CEO
Michael A. Metzger
IPO Date
2016-03-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$18.58
Prev. Close
$18.39
Day Low
$18.10
Day High
$18.58
52W Low
$8.59
52W High
$25.59
Market Cap
$1.63B
Volume
1.25M
| 1 Apr 2026 |
| Goldman Sachs |
| Buy |
| Buy |
| maintain |
| 31 Mar 2026 | Mizuho | Outperform | Outperform | maintain |
| 9 Mar 2026 | JP Morgan | Overweight | Overweight | maintain |
| 2 Mar 2026 | Citigroup | Buy | Buy | maintain |
| 27 Jan 2026 | Mizuho | Outperform | Outperform | maintain |
| 9 Dec 2025 | BTIG | Buy | Buy | maintain |
| 24 Nov 2025 | Barclays | Overweight | Overweight | maintain |